Medicine and Dentistry
Mesenchymal-Epithelial Transition
100%
Transforming Growth Factor Beta
66%
Androgen Receptor
44%
TGF Beta Signaling
44%
Prostate Cancer
44%
Metastatic Carcinoma
33%
Therapeutic Procedure
33%
Combination Therapy
22%
Androgen
22%
Antiandrogen
22%
Cycling
11%
Enzalutamide
11%
Castration Resistant Prostate Cancer
11%
Signal Transduction
11%
Prostate Tumor
11%
Revertant
11%
Serositis
11%
Tumor Progression
11%
Growth
11%
Epithelial Cell
11%
Cell Polarity
11%
Galunisertib
11%
Cancer Growth
11%
Programmed Cell Death
11%
Carcinogenesis
11%
Membrane Receptor
11%
Tumor Invasion
11%
Cancer Cell
11%
Pharmacology, Toxicology and Pharmaceutical Science
Transforming Growth Factor Beta
66%
Prostate Cancer
44%
Androgen Receptor
44%
Metastasis
33%
Beta Adrenergic Receptor
22%
Androgen
22%
Antiandrogen
22%
Prostate Tumor
11%
Tumor Invasion
11%
Cancer Growth
11%
Membrane Receptor
11%
Galunisertib
11%
Mouse Model
11%
Enzalutamide
11%
Carcinogenesis
11%
Tumor Growth
11%
Castration Resistant Prostate Cancer
11%
Biochemistry, Genetics and Molecular Biology
Mesenchymal-Epithelial Transition
100%
TGF Beta Signaling
44%
TGF-Beta
44%
Androgen Receptor
44%
Apoptosis
11%
Membrane
11%
Cancer Cell
11%
Cell Polarity
11%
Tumor Progression
11%
Mouse Model
11%
Biomechanics
11%
Growth
11%
Enzalutamide
11%
Cycling
11%
Signal Transduction
11%
Revertant
11%